Pairing Bariatric Procedure with Diabetes Drug Increases Weight Loss
Endoscopic sleeve gastroplasty combined with semaglutide produces results similar to surgery Bethesda, MD (May 14, 2021) — Combining minimally invasive endoscopic sleeve gastroplasty (ESG) with the diabetes drug semaglutide can provide additional significant weight loss for patients who are not candidates for invasive weight-loss surgery, according to research that was